Between late 2025 and mid-2026, nine hedge funds reduced their spot Bitcoin ETF holdings by about 68,000 BTC, driven by yield comparisons with Treasury bills rather than loss of confidence in Bitcoin. Meanwhile, wealth platforms and sovereign funds increased their Bitcoin ETF exposure, signaling a shift in institutional demand. Although ETF holdings recovered somewhat after June 2026, October saw net outflows and slower corporate buying. Upcoming Q3 13F filings due November 16 will clarify if wealth managers continue to buy, potentially confirming a Bitcoin market recovery, or if hedge fund selling persists, risking a fragile rebound.
Galaxy Research's report on hedge funds cutting Bitcoin ETF exposure provides context as of Oct 28, 2026 23:22 WIB. For readers following cryptocurrency markets, here is Pluang's snapshot: out of 50 major cryptocurrencies priced on Pluang, 35 rose and 14 fell today. Notable movers include FTM (Fantom) down 2.05% to Rp11.382, XNO (Nano) up 1.94% to Rp6.135, and NEO (Neo) up 1.87% to Rp38.222 with a Pluang order activity of 35% Sell / 65% Buy and a typical hold time of 97 days. The most notable figure is the 65% buy activity on NEO.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
